Menu Search

Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase23 Oct 2026Rapport Therapeutics, Inc.RAPP:NMQRamiro SanchezIndependent Director3,60027.35
USD		98.48k USD
Purchase23 Oct 2026MSC Industrial Direct Co., Inc.MSM:NYQReuben E. SloneIndependent Director370115.65
USD		42.79k USD
Purchase23 Oct 2026MSC Industrial Direct Co., Inc.MSM:NYQReuben E. SloneIndependent Director63116.52
USD		7.34k USD
Purchase23 Oct 2026City of London Investment Group PLCCLIG:LSERian Avery Arthur DartnellNon-Executive Director,Chairman4,8804.41
GBP		21.50k GBP
Purchase23 Oct 2026BlackRock Latin American Investment Trust PlcBRLA:LSECraig Mccowan ClelandNon-Executive Director5,0004.60
GBP		23.00k GBP
Purchase23 Oct 2026Earnz PLCEARN:LSEElizabeth Janet LakeExecutive Director,Chief Financial Officer2,500,0000.04
GBP		100.00k GBP
Purchase23 Oct 2026Verici DX PLCVRCI:LSEJulian Huw BainesNon-Executive Director,Chairman10,000,0000.002
GBP		20.00k GBP
Purchase23 Oct 2026Verici DX PLCVRCI:LSESara Jane BarringtonExecutive Director,Chief Executive Officer5,000,0000.002
GBP		10.00k GBP
Sale22 Oct 2026Lindblad Expeditions Holdings, Inc.LIND:NAQSven-Olof LindbladCo-Chairman of the Board60,49735.59
USD		2.15m USD
Sale22 Oct 2026Lindblad Expeditions Holdings, Inc.LIND:NAQSven-Olof LindbladCo-Chairman of the Board7,47736.42
USD		272.32k USD
Purchase22 Oct 2026Rathbones Group PLCRAT:LSEMichelle Sylvia ScrimgeourNon-Executive Director1,53016.24
GBP		24.85k GBP
Purchase22 Oct 2026Rathbones Group PLCRAT:LSEMichelle Sylvia ScrimgeourNon-Executive Director1,52516.30
GBP		24.86k GBP
Sale22 Oct 2026Block, Inc.XYZ:NYQAnthony EisenDirector6,00078.06
USD		468.36k USD
Sale22 Oct 2026CME Group Inc.CME:NSQMartin J. GepsmanIndependent Director400302.50
USD		121.00k USD
Purchase22 Oct 2026Rapport Therapeutics, Inc.RAPP:NMQJohn M. MaraganoreIndependent Director8,23926.38
USD		217.34k USD
26755 total results

Director dealings news

Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
www.morningstar.com